Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1020405

registered interest
date	05/12/2018
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Medicines and Healthcare products Regulatory Agency
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA) and with reference to the transition period set out in the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, if the MHRA will be recognised as an EU competent authority under EU Regulations (a) Medical Devices Directive, (b) in-vitro diagnostic medical devices, and (c) Medical Devices Regulation during that period.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	199326
answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as an EU competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p><strong></strong><br><br></p><p> </p> answering member constituency Daventry answering member printed Chris Heaton-Harris question first answered 10/12/2018 15:48:34 answering member 3977 label Biography information for Chris Heaton-Harris
tabling member	1436 label Biography information for Paul Farrelly

58438

registered interest
date	05/06/2014
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Victim Support Schemes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, what assessment he has made of the effect on funding available for victims' services of devolution to police and crime commissioners.
tabling member constituency	Bolton North East
tabling member printed	Mr David Crausby
uin	199326
answer	answer is ministerial correction date of answer 12/06/2014 answer text <p /> <p /> <p>From 1 October 2014 the majority of support services for victims of crime will be commissioned at the local level by democratically elected and publicly accountable Police and Crime Commissioners and this Government is making more money than ever before available to ensure that victims receive the vital support they require.</p><p> </p><p>PCC's with their knowledge of local victims' needs are uniquely placed to ensure that available funding is targeted where most required to help victims of crime to both cope with and, where possible, recover from the impacts of crime.</p><p> </p><p>PCCs are also ideally placed to co-commission with other local commissioners such as Health or Local Authorities, thereby reducing duplication and achieving better value for money.</p> answering member constituency Ashford answering member printed Damian Green question first answered 12/06/2014 09:22:44 answering member 76 label Biography information for Damian Green
tabling member	437 label Biography information for Sir David Crausby